quinacrine has been researched along with Eye Disorders in 8 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Quinacrine does not cause retinopathy, but it has more cutaneous side effects than the other two agents." | 2.36 | Antimalarials. ( Koranda, FC, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McCune, WJ | 1 |
| Gonzalez-Rivera, T | 1 |
| Bower, BD | 1 |
| Jeavons, PM | 1 |
| Koranda, FC | 1 |
| Tanenbaum, L | 1 |
| Tuffanelli, DL | 1 |
| Huriez, C | 1 |
| Desmons, F | 1 |
| Gautier, G | 1 |
| Meier-Ruge, W | 1 |
| Carr, RE | 1 |
| Henkind, P | 1 |
| Rothfield, N | 1 |
| Siegel, IM | 1 |
| Hermann, P | 1 |
| Lefranc, E | 1 |
| Sourdille, P | 1 |
3 reviews available for quinacrine and Eye Disorders
| Article | Year |
|---|---|
Antimalarials.
Topics: Antimalarials; Chloroquine; DNA; Eye Diseases; Humans; Hydroxychloroquine; Quinacrine; RNA; Skin Dis | 1981 |
Antimalarial agents. Chloroquine, hydroxychloroquine, and quinacrine.
Topics: Abnormalities, Drug-Induced; Anti-Inflammatory Agents; Chloroquine; DNA; Eye Diseases; Female; Hemat | 1980 |
Drug induced retinopathy.
Topics: Adsorption; Animals; Antineoplastic Agents; Chloroquine; Drug-Related Side Effects and Adverse React | 1969 |
5 other studies available for quinacrine and Eye Disorders
| Article | Year |
|---|---|
Should very low doses of hydroxychloroquine and quinacrine be employed in combination for long-term maintenance of remission in systemic lupus to reduce the risk of ocular toxicity?
Topics: Antimalarials; Dose-Response Relationship, Drug; Drug Therapy, Combination; Eye Diseases; Follow-Up | 2015 |
The "happy puppet" syndrome.
Topics: Child; Chlordiazepoxide; Electroencephalography; Epilepsy; Ethosuximide; Eye Diseases; Facial Expres | 1967 |
[Complications with synthetic antimalarials].
Topics: Antimalarials; Asthenia; Central Nervous System Diseases; Chloroquine; Drug Eruptions; Eczema; Eye D | 1969 |
Ocular toxicity of antimalarial drugs. Long-term follow-up.
Topics: Adolescent; Adult; Antimalarials; Child; Child, Preschool; Chloroquine; Electrooculography; Electror | 1968 |
[Ocular accidents from synthetic antimalarials (apropos of 4 new cases)].
Topics: Adolescent; Antimalarials; Child; Chloroquine; Electroretinography; Eye Diseases; Humans; Quinacrine | 1966 |